Increase in investments in R&D, rapid advancements in technology, and surge in biomedical applications are expected to drive the growth of the global 3D printing healthcare market. The market across North America held the lion’s share in 2018, accounting for more than two-fifths of the market. However, the system segment held the largest share in 2018, contributing more than half of the market.
As per the report published by Allied Market Research, the global 3D printing healthcare market accounted for $972.6 million in 2018 and is projected to reach $3.69 billion by 2026, growing at a CAGR of 18.2% from 2019 to 2026.
Rise in investments in R&D activities, rapid technological developments in 3D printing, and surge in biomedical applications have boosted the growth of the global 3D printing healthcare market. Moreover, presence of huge patient pool supplemented the market growth. However, dearth of skilled labor, rise in reimbursement issues, and high costs related to 3D printing hamper the market. On the contrary, rise in pharmaceutical applications and presence availability of bioprinting organs are expected to create lucrative opportunities in the near future.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/834
The global 3D printing healthcare market is segmented on the basis of component, technology, application, end user, and geography. Based on component, the market is divided into system/device, materials, services. The system segment held the largest share in 2018, contributing more than half of the market and is expected to continue its dominance throughout the forecast period. However, the materials segment is projected to register the fastest CAGR of 20.0% from 2019 to 2026.
On the basis of technology, the market is divided into droplet deposition (DD), photopolymerization, laser beam melting, electronic beam melting (EBM), and laminated object manufacturing. Based on application, the market is segmented into external wearable devices, clinical study devices, implants, and tissue engineering. The external wearable devices segment dominated the market, contributing nearly three-fifths of the market and would continue its dominance. However, the tissue engineering segment is projected to register the highest CAGR of 22.2% during the forecast period.
The global 3D printing healthcare market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2018, accounting for more than two-fifths of the market. However, the market across Asia-Pacific is projected to manifest the fastest CAGR of 19.7% during the study period.
Scope of the Report:
| Report Attribute | Details |
| Market size available for years | 2019 – 2026 |
| Base year considered | 2020 |
| Forecast period | 2019 – 2026 |
| Forecast units | Value (USD) |
| Segments covered | By Component, By Technology, By Application, By End User, By Region |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
The market report provides an in-depth analysis of the major market players such as Exone, 3D Systems Corporation, Materialise NV, Formlabs, GE, Organovo Holdings, Inc., Oxferd Performance Materials, Inc., SLM Solutions Group AG, Proto Labs, and Stratasys Ltd.
Related Reports:
Endoscopy Devices Market by Product Type (Endoscopy Devices, Mechanical Endoscopic Equipment, Visualization & Documentation Systems, Accessories, and Others), Hygiene (Single-use, Reprocessing, and Sterilization), Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Gynecology Endoscopy, ENT Endoscopy, and Others), and End User (Hospitals, Ambulatory Surgery Centers & Clinics, and Others): Opportunity Analysis and Industry Forecast, 2019–2026
Biopsy Devices Market by Product (Needle-Based Biopsy Instruments, Biopsy Forceps, Localization Wires, and Other Products), Application (Breast Biopsy, Gastroenterology Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Kidney Biopsy, Gynecological Biopsy, and Others), Imaging Technology (MRI–guided Biopsy, Stereotactic–guided Biopsy, Ultrasound–guided Biopsy, CT scan, and Others), and End User (Diagnostic and Imaging Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht
